Experimental design
In a randomised, placebo-controlled, single-blind, cross-over design study participants completed two trials after acute consumption of either EGCG or a placebo (PLAC) supplement after an overnight fast. Principal investigator was responsible for generating the random allocation sequence, enrolling participants, and assigning interventions. Following a two-hour monitoring period participants performed a continuous graded cycle exercise test to volitional exhaustion. There was at least a 7-day washout period between trials. No reported losses and exclusions after randomisation in any group. Due to the non-clinical exploratory nature of the randomised cross-over study it was registered following ethical approval.